Chronic News and Research

RSS

Supportive data from a preclinical study of SCY-635 to be presented

Drug discovery company SCYNEXIS, Inc. today announced that supportive data from a preclinical study of the Company’s lead product candidate for hepatitis C (HCV), SCY-635, will be presented in a poster session at the 60th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) being held in Boston, MA, October 30-November 3, 2009.

29 Oct 2009

Recipients of the second round of funding under CLL/SLL Research Initiative announced by LRF

The Lymphoma Research Foundation (LRF) is pleased to announce that David Frank, MD, PhD of the Dana-Farber Cancer Institute and Thomas Kipps, MD, PhD, Moores Cancer Center, University of California, San Diego are the recipients of the second round of funding under the Foundation's Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) Research Initiative.

29 Oct 2009

Iron-folic acid supplements during pregnancy can reduce offspring’s mortality rate

Offspring whose mothers had been supplemented with iron-folic acid during pregnancy had dramatically reduced mortality through age 7, according to researchers at the Johns Hopkins Bloomberg School of Public Health.

29 Oct 2009

Pregnant women with symptoms of depression have a stronger biological reaction to the seasonal flu vaccine

Pregnant women with significant symptoms of depression tend to have a stronger biological reaction to the seasonal flu vaccine than do women with lower depression levels, according to a new study.

29 Oct 2009

TNF therapy does not raise cancer risk in RA patients; overall cancer risk comparable to those not taking immunosuppressive drugs

A recent study by Swedish researchers found that rheumatoid arthritis (RA) patients did not experience an elevated cancer risk in the first 6 years after starting anti-tumor necrosis factor (TNF) therapy.

29 Oct 2009

Lifestyle and genetic factors are considered to play a major role in "Asian paradox"

Although Helicobacter pylori (H. pylori) has been classified as a class I (or definite) carcinogen by World Health Organization (WHO), the controversy as to why only a minority of infected patients develop gastric cancer still remains. Moreover, in Asian countries such as Indonesia, Japan, China, and Thailand, where the H. pylori infection rates are similar, there is a significant difference regarding the outcome of gastric cancer. That fact has been termed the "Asian paradox".

29 Oct 2009

Depressed people more likely to overstate the frequency of physical symptoms

New research shows people who feel depressed tend to recall having more physical symptoms than they actually experienced. The study indicates that depression -- not neuroticism -- is the cause of such over-reporting.

29 Oct 2009

Scientists identify genetic mutations that may put individuals at increased risk of fungal infections

Two genetic mutations that may put individuals at increased risk of fungal infections have been identified by scientists from UCL and Radboud University, increasing understanding about the genetic basis of these infections and potentially aiding the development of new treatments.

29 Oct 2009

Moores UCSD Cancer Center awarded $20 million for cancer research

Researchers led by Moores UCSD Cancer Center Director Dennis A. Carson, MD, professor of medicine, and Catriona Jamieson, MD, PhD, assistant professor of medicine and director of the Cancer Stem Cell Research Program at the Moores UCSD Cancer Center have been awarded $20 million over four years to develop novel drugs against leukemia stem cells.

28 Oct 2009

WHO identifies five major causes of premature death

Targeting the five major causes of premature death could increase global life expectancy by almost five years, the WHO said Tuesday, Reuters reports. According to a WHO's Global Health Risks report, which looked at 24 major health risks, "[p]oor childhood nutrition, unsafe sex, alcohol, bad sanitation and hygiene, and high blood pressure are to blame for around a quarter of the 60 million premature deaths around the world each year," the news service writes.

28 Oct 2009

Quinnova Pharmaceuticals raises $17.4 million through Series B financing

Safeguard Scientifics, Inc., a holding company that builds value in growth-stage life sciences and technology companies, today announced it led a $17.4 million Series B financing round for Quinnova Pharmaceuticals, Inc., with participation from existing investors Thomas, McNerney & Partners and H.I.G. BioVentures.

28 Oct 2009

Accenture Innovation Center for Health launched to tackle challenges facing the global health industry

Accenture (NYSE: ACN) today launched the Accenture Innovation Center for Health in response to the growing global demand for insights into and strategies to confront the top health issues and challenges affecting citizens worldwide. The center serves as the focal point for Accenture’s thought capital and proven assets for tackling the most pressing challenges facing the global health industry.

28 Oct 2009

North Dakota congressional delegation praised for recognizing seniors’ care needs as priority in final bill

With North Dakota seniors facing cuts of up to $75 million in their Medicare-funded nursing home care over the next ten years as a result of pending health reform legislation in Congress, North Dakota and national long term care leaders conducted a North Dakota media teleconference today to praise the North Dakota congressional delegation for recognizing the specific concerns of seniors and caregivers, and ensuring the leadership in their respective chambers clearly understand why seniors' care needs must be a priority in a final bill.

28 Oct 2009

Nashboro Village Family Dental's initiative for childhood cancer

On Saturday, November 21, 2009 Nashboro Village Family Dental will present our First Annual Super Talent and All-Star Show. Hosted by Lelan Statom, WTVF, NewsChannel 5, this event will benefit Operation Stand Down and one of our patients that is battling chronic childhood cancer.

28 Oct 2009

Controlled trial in UC meets primary endpoint of non- inferiority for reducing ulcerative colitis

Results from the largest prospective controlled ulcerative colitis (UC) trial conducted to date, called the QD dosing investigation for efficacy IN UC maintenance (QDIEM), found that once-daily dosing of Asacol(R) (mesalamine) delayed-release 400 mg tablets at 1.6-2.4 g/day was comparable to twice-daily dosing for the maintenance of remission in patients with UC.

28 Oct 2009

MolecularMD moves core operations to expanded facility

MolecularMD Corp announced today that it has moved their core operations to a expanded dedicated facility with capacity and functionality to support the expansion of its cancer molecular diagnostics business.

28 Oct 2009

Innovative new partnership to provide free HIV testing and HIV/AIDS medical care in Saint-Petersburg

AIDS Healthcare Foundation (AHF), Saint-Petersburg Government Healthcare Institution’s Center for Prevention and Control of Infectious Diseases; AIDS, Statistics, Health, a respected regional non-governmental organization (NGO); and Saint-Petersburg Government Healthcare Institution’s Policlinic N109 are honored to announce that they are forming an innovative new partnership to provide free HIV testing and prevention services and HIV/AIDS medical care in Saint-Petersburg, Russia’s second largest city.

28 Oct 2009

Study of ‘real-life’ experiences of patients undergoing 5-ASA treatment for ulcerative colitis

InfoMedics, Inc., a company that engages patients and physicians to communicate better through the delivery of treatment feedback, has poster presentations at three industry conferences in October 2009. All of these studies provide a unique look at real-life patient feedback regarding experiences with medications for chronic conditions including ulcerative colitis (UC) and attention-deficit/hyperactivity disorder (ADHD) in adults and children.

28 Oct 2009

Patient self-referral to physiotherapy proven to be safe, and results in better health outcomes

Today in Washington, DC, physiotherapists from around the world heard that direct patient access and self-referral to physiotherapy improves public health. Patient self-referral and direct access is proven to be safe, and results in better health outcomes, more timely care, higher patient satisfaction, and lower costs.

28 Oct 2009

Treatment with TYSABRI reduces the rate of hospitalization in Crohn’s patients

Elan Corporation, plc and Biogen Idec today announced data showing that treatment with TYSABRI® (natalizumab) significantly reduced the rate of hospitalization compared with placebo in patients with moderate–to–severe Crohn’s disease during both induction and maintenance treatment.

28 Oct 2009

Chronic News and Research

Supportive data from a preclinical study of SCY-635 to be presented

Recipients of the second round of funding under CLL/SLL Research Initiative announced by LRF

Iron-folic acid supplements during pregnancy can reduce offspring’s mortality rate

Pregnant women with symptoms of depression have a stronger biological reaction to the seasonal flu vaccine

TNF therapy does not raise cancer risk in RA patients; overall cancer risk comparable to those not taking immunosuppressive drugs

Lifestyle and genetic factors are considered to play a major role in "Asian paradox"

Depressed people more likely to overstate the frequency of physical symptoms

Scientists identify genetic mutations that may put individuals at increased risk of fungal infections

Moores UCSD Cancer Center awarded $20 million for cancer research

WHO identifies five major causes of premature death

Quinnova Pharmaceuticals raises $17.4 million through Series B financing

Accenture Innovation Center for Health launched to tackle challenges facing the global health industry

North Dakota congressional delegation praised for recognizing seniors’ care needs as priority in final bill

Nashboro Village Family Dental's initiative for childhood cancer

Controlled trial in UC meets primary endpoint of non- inferiority for reducing ulcerative colitis

MolecularMD moves core operations to expanded facility

Innovative new partnership to provide free HIV testing and HIV/AIDS medical care in Saint-Petersburg

Study of ‘real-life’ experiences of patients undergoing 5-ASA treatment for ulcerative colitis

Patient self-referral to physiotherapy proven to be safe, and results in better health outcomes

Treatment with TYSABRI reduces the rate of hospitalization in Crohn’s patients

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News